Sarah brings broad legal experience from the biotechnology industry to her role.
She was most recently Chief Legal Officer at Absci, a generative AI drug creation company focused on biologics. She was previously General Counsel at Neuvogen and held roles specializing in intellectual property at Amgen, Onyx Pharmaceuticals and the World Intellectual Property Organization. She started her legal career in private practice.
Sarah earned dual undergraduate degrees in chemistry and metallurgical & materials engineering from South Dakota Mines, a PhD in materials science and engineering from The Pennsylvania State University, and her Juris Doctorate from DePaul University College of Law. She is a National Science Foundation Fellow and an inventor on various patents directed to nano-enabled therapeutics and drug delivery technologies. Sarah sits on the Board of the BioIndustry Association (BIA), bringing extensive expertise at the intersection of law, business strategy, and frontier technology to the UK life sciences ecosystem.
